Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis ; volume:14 ; number:2 ; year:2021 ; pages:733-738 ; extent:6
Case reports in oncology ; 14, Heft 2 (2021), 733-738 (gesamt 6)

Creator: Mohammed, Turab
Mangeshkar, Shaunak
Rathmann, Joerg

DOI: 10.1159/000516274

URN: urn:nbn:de:101:1-2021090900384242093087

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Mohammed, Turab
Mangeshkar, Shaunak
Rathmann, Joerg

Other Objects (12)

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report

Hypersensitivity pneumonitis

RADIATION PNEUMONITIS

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Drug-induced uveitis

Hypersensitivity pneumonitis : a clinical approach

Interstitial pneumonitis following intrapleural chemotherapy

Successful cemented femoral arthroplasties reveal very often stiffened bone structures

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

Drug-induced neurological disorders

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report

Hypersensitivity pneumonitis

RADIATION PNEUMONITIS

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Drug-induced uveitis

Hypersensitivity pneumonitis : a clinical approach

Interstitial pneumonitis following intrapleural chemotherapy

Successful cemented femoral arthroplasties reveal very often stiffened bone structures

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

Drug-induced neurological disorders

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report

Hypersensitivity pneumonitis

RADIATION PNEUMONITIS

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Drug-induced uveitis

Hypersensitivity pneumonitis : a clinical approach

Interstitial pneumonitis following intrapleural chemotherapy

Successful cemented femoral arthroplasties reveal very often stiffened bone structures

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

Drug-induced neurological disorders

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report

Hypersensitivity pneumonitis

RADIATION PNEUMONITIS

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Drug-induced uveitis

Hypersensitivity pneumonitis : a clinical approach

Interstitial pneumonitis following intrapleural chemotherapy

Successful cemented femoral arthroplasties reveal very often stiffened bone structures

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

Drug-induced neurological disorders

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report

Hypersensitivity pneumonitis

RADIATION PNEUMONITIS

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Drug-induced uveitis

Hypersensitivity pneumonitis : a clinical approach

Interstitial pneumonitis following intrapleural chemotherapy

Successful cemented femoral arthroplasties reveal very often stiffened bone structures

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

Drug-induced neurological disorders

Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report

Hypersensitivity pneumonitis

RADIATION PNEUMONITIS

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

Drug-induced uveitis

Hypersensitivity pneumonitis : a clinical approach

Interstitial pneumonitis following intrapleural chemotherapy

Successful cemented femoral arthroplasties reveal very often stiffened bone structures

Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib

Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab

Drug-induced neurological disorders

Related objects

Reset password